SCHEMBL7789947

SCHEMBL7789947

C1=CCOOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1111188 0.78
SCHEMBL9053351 0.74
SCHEMBL2554291 0.71
SCHEMBL30378180 0.67
SCHEMBL6517038 0.67
SCHEMBL1762395 0.67
SCHEMBL1434131 0.60
SCHEMBL248869 0.60
Hydrogen Sulfide SCHEMBL9073663 0.60
SCHEMBL27572 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118667140-A Oxa-poly cyclohexene carbonate polymer material and synthetic method thereof 大连理工大学 2024-09-20 CN claimed
EP-4724439-A1 HETEROARYL DERIVATIVES AS DDRS INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2026-04-15 EP disclosed
EP-4720067-A1 BICYCLIC HETEROARYLAMIDES HAVING GPR68 MODULATING ACTIVITY Recursion Pharmaceuticals, Inc. (US) 2026-04-08 EP disclosed
US-20260055126-A1 SMALL MOLECULE COMPOUNDS WITH PHOSPHORYLATED ARYL STRUCTURES AND USE THEREOF HANGZHOU PHECDAMED CO LTD (CN) 2026-02-26 US disclosed
EP-4678644-A1 SUBSTITUTED DIHYDROTHIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Shanghai Yidi Biotechnology Co., Ltd. (CN) 2026-01-14 EP disclosed
EP-4608401-A2 MK2 INHIBITORS AND USES THEREOF Bristol-Myers Squibb Company (US) 2025-09-03 EP disclosed
EP-4592302-A1 SMALL MOLECULE COMPOUND HAVING PHOSPHORYLATED ARYL STRUCTURE, AND USE THEREOF Hangzhou Phecdamed Co., Ltd. (CN) 2025-07-30 EP disclosed
EP-4587126-A1 COMPOUNDS FOR TARGETED PROTEIN DEGRADATION Amphista Therapeutics Ltd (GB) 2025-07-23 EP disclosed
EP-4585596-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF Shanghai Yingli Pharmaceutical Co., Ltd (CN) 2025-07-16 EP disclosed
CN-115716804-B Method for preparing 10-substituted-5H-dibenzo (b, f) azepine compound 上海中医药大学 2025-05-30 CN disclosed
US-20130189256-A1 ANTIPROLIFERATIVE COMPOUNDS, CONJUGATES THEREOF, METHODS THEREFOR, AND USES THEREOF MEDAREX, INC. (US) 2013-07-25 US disclosed
US-20120157647-A1 Polymeric Compositions and Polymerization Initiators Using Photo-Peroxidation Process FINA TECHNOLOGY, INC. (US) 2012-06-21 US disclosed
US-20090043065-A1 Singlet oxygen oxidized materials and methods of making and using same FINA TECHNOLOGY, INC. 2009-02-12 US disclosed
US-20090043065-A1 Singlet oxygen oxidized materials and methods of making and using same FINA TECHNOLOGY, INC. 2009-02-12 US disclosed
US-6300515-B1 ISOMERIZING AT LEAST ONE ALLYLIC SUBSTRATE HAVING ACYLOXYL GROUP OR HYDROXYL GROUP AT ALLYL POSITION THEREOF, TO PRODUCE CORRESPONDING ALLYLIC ISOMER, IN PRESENCE OF CATALYST COMPRISING GROUP VIII-X METAL COMPOUND AND PHOSPHITE COMPOUND MITSUBISHI CHEMICAL CORPORATION (JP) 2001-10-09 US disclosed
JP-2001213875-A DERIVATIVE OF 3,6-DIHYDRO-1,2-DIOXIN AND ANTITUMOR AGENT SAGAMI CHEM RES CENTER 2001-08-07 JP disclosed
US-4410713-A Preparation of furan compounds E. I. DU PONT DE NEMOURS & CO. (US) 1983-10-18 US disclosed
US-3894920-A Process for preparing alkyl-substituted 3,6-dihydro-o-dioxin derivatives SAGAMI CHEM RES 1975-07-15 US disclosed
US-3894920-A Process for preparing alkyl-substituted 3,6-dihydro-o-dioxin derivatives SAGAMI CHEM RES 1975-07-15 US disclosed
US-3855246-A AKLYL-SUBSTITUTED 3,6-DIHYDRO-O-DIOXIN DERIVATIVES AND PROCESS FOR THEIR PREPARATION SAGAMI CHEM RES 1974-12-17 US disclosed